Type 2 Diabetes (T2D) Clinical Trials

Find Type 2 Diabetes (T2D) Clinical Trials Near You

Testing the Feasibility of Blood Flow Restriction Training to Enhance the Health Benefits of Exercise in Individuals With Type 2 Diabetes: a Pilot Randomized Controlled Trial

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this trial is to learn if blood flow restriction training with treadmill walking is possible for individuals living with type 2 diabetes. It will also learn about how the blood flow restriction with treadmill walking could improve health. The main questions it aims to answer are: Is 6 weeks of treadmill walking with blood flow restriction reasonable for people with type 2 diabetes to perform? Does treadmill walking with blood flow restriction training help manage type 2 diabetes better than just treadmill walking? Researchers will compare treadmill walking with blood flow restriction to treadmill walking without blood flow restriction to see if blood flow restriction works to manage type 2 diabetes based on fitness and blood sugar levels. Participants will: Perform treadmill walking with or without blood flow restriction for 96 minutes a week for 6 weeks. Visit the lab before and after the exercise for tests and questionnaires.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Maximum Age: 64
Healthy Volunteers: f
View:

• Diagnosed with type 2 diabetes (5.7% \< HbA1c \< 9.0%)

• Not regularly physically active (150 mins moderate-vigorous physical activity per week)

Locations
Other Locations
Canada
Cardiometabolic Exercise & Lifestyle Laboratory
RECRUITING
Fredericton
Human Performance & Health Research Laboratory
RECRUITING
Guelph
Exercise Metabolism and Inflammation Laboratory
NOT_YET_RECRUITING
Okanagan
Contact Information
Primary
Martin Senechal, PhD
martin.senechal@unb.ca
506-451-6889
Backup
Jamie Burr, PhD
burrj@uoguelph.ca
519-824-4120
Time Frame
Start Date: 2026-01-01
Estimated Completion Date: 2028-12
Participants
Target number of participants: 60
Treatments
Experimental: Aerobic Training with Blood Flow Restriction
Participants will perform aerobic training with blood flow restriction.
Active_comparator: Standard Aerobic Training
Participants will perform aerobic training.
Related Therapeutic Areas
Sponsors
Collaborators: University of Guelph, University of British Columbia, Diabetes Canada
Leads: University of New Brunswick

This content was sourced from clinicaltrials.gov